SITAZAN

Description

Composition: Sitagliptin + Metformin

Product Type: Tablet

Quantity: 14 tablets

Strength/Dosage: 50 mg/500 mg, 50 mg/1000 mg per tablet

Indications:

Management of type 2 diabetes mellitus in adults as an adjunct to diet and exercise.
Improvement of glycemic control in patients inadequately controlled on metformin alone.
Combination therapy for patients requiring both sitagliptin and metformin to manage blood glucose levels.
Reduction of fasting and postprandial blood glucose levels in type 2 diabetes.
Prevention of long-term complications associated with poorly controlled diabetes, such as cardiovascular disease.